相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthesis and biological evaluation of N-substituted 3-oxo-1,2,3,4-tetrahydro-quinoxaline-6-carboxylic acid derivatives as tubulin polymerization inhibitors
Jianguo Qi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Imidazo[1,2-a]pyrazine, Imidazo[1,5-a]quinoxaline and Pyrazolo [1,5-a]quinoxaline derivatives as IKK1 and IKK2 inhibitors
Cindy Patinote et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity
Guilherme Felipe dos Santos Fernandes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Synthesis, in vitro antimicrobial, antioxidant, and antidiabetic activities of thiazolidine-quinoxaline derivatives with amino acid side chains
Suhas A. Shintre et al.
MEDICINAL CHEMISTRY RESEARCH (2017)
Quinoxalin-2(1H)-one derived AMPA-receptor antagonists: Design, synthesis, molecular docking and anticonvulsant activity
Abdel-Ghany A. El-Helby et al.
MEDICINAL CHEMISTRY RESEARCH (2017)
Asymmetric 2D benzodithiophene and quinoxaline copolymer for photovoltaic applications
Zhe Liu et al.
JOURNAL OF MATERIALS CHEMISTRY C (2017)
Synthesis of Benzo[g]quinoxaline-5,10-dione Based Pyridine Derivatives and their Antimycobacterial Activity
Shiv Kumar et al.
ORIENTAL JOURNAL OF CHEMISTRY (2017)
Novel quinoxalinyl chalcone hybrid scaffolds as enoyl ACP reductase inhibitors: Synthesis, molecular docking and biological evaluation
Vidya Desai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPARγ and SUR agonists
Mohammed K. Ibrahim et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents
Yuanhu Pan et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Quinoxaline-based inhibitors of Ebola and Marburg VP40 egress
H. Marie Loughran et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis
Mery Santivañez-Veliz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Design, synthesis and anti-HIV activity of novel quinoxaline derivatives
Saloni B. Patel et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Synthesis and evaluation of in vitro antiproliferative activity of new ethyl 3-(arylethynyl)quinoxaline-2-carboxylate and pyrido[4,3-b] quinoxalin-1(2H)-one derivatives
Majdi Hajri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Pyridine-catalyzed synthesis of quinoxalines as anticancer and anti-tubercular agents
Atulkumar A. Kamble et al.
MEDICINAL CHEMISTRY RESEARCH (2016)
Diagnostic tests: Testing for tuberculosis
Anastasios Konstantinos
Australian Prescriber (2016)
Re-engineering nalidixic acid's chemical scaffold: A step towards the development of novel anti-tubercular and anti-bacterial leads for resistant pathogens
Ramalingam Peraman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid
Gecioni Loch-Neckel et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Quinoxaline, its derivatives and applications: A State of the Art review
Joana A. Pereira et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents
Juliana Cogo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Antimycobacterial activity of natural products and synthetic agents: Pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis
Dakshina U. Ganihigama et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1
Joao Neres et al.
ACS CHEMICAL BIOLOGY (2015)
Quinoline: A promising antitubercular target
Rangappa S. Keri et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
Present status of quinoxaline motifs: Excellent pathfinders in therapeutic medicine
Olayinka Oyewale Ajani
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Synthesis and in vitro evaluation of 4-trichloromethylpyrrolo[1,2-a]quinoxalines as new antiplasmodial agents
Nicolas Primas et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Emergence of pyrido quinoxalines as new family of antimalarial agents
A. Chandra Shekhar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Echinomycin biosynthesis
Michio Sato et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2013)
Sulphonamido-quinoxalines: Search for anticancer agent
Rahul Ingle et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Design, synthesis and structure-activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptor
Shadia A. Galar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Novel quinoxaline 1,4-di-N-oxide derivatives as new potential antichagasic agents
Enrique Torres et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery of novel 2-piperidinol-3-(arylsulfonyl)quinoxalines as phosphoinositide 3-kinase α (PI3Kα) inhibitors
Peng Wu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: Discovery of quinoxaline-based hybrid compounds with AChE, H3R and BACE 1 inhibitory activities
Wenhai Huang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-Mycobacterium tuberculosis agents
Enrique Torres et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitors
Lei You et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Synthesis, In Vitro Antitubercular Activity and 3D-QSAR of Novel Quinoxaline Derivatives
Ayarivan Puratchikody et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2011)
Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: Search for anticancer agent
Malleshappa N. Noolvi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
The Quinoxaline Anti-Tumor Agent (R+)XK469 Inhibits Neuroblastoma Tumor Growth
Nisha C. Kakodkar et al.
PEDIATRIC BLOOD & CANCER (2011)
New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents
Saioa Ancizu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors
Carole Pissot-Soldermann et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones
P. Ramalingam et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
E-2-[3-(3,4-Dichlorophenyl)-1-oxo-2-propenyl]-3-methylquinoxaline-1,4-dioxide: A lead antitubercular agent which alters mitochondrial respiration in rat liver
Umashankar Das et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis, cytotoxicity, antiviral activity and interferon inducing ability of 6-(2-aminoethyl)-6H-indolo[2,3-b]quinoxalines
Marina O. Shibinskaya et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis of new series of quinoxaline based MAO-inhibitors and docking studies
Sherine N. Khattab et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis of some new pyrimido[2′,1′:2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents
A. A. Abu-Hashem et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives
Elsa Moreno et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Design of novel iron compounds as potential therapeutic agents against tuberculosis
M. Belen Tarallo et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Selective activity against Mycobacterium tuberculosis of new quinoxaline 1,4-di-N-oxides
Esther Vicente et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase
John Porter et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Discovery of 6-({4-[2-(4-tert-Butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): An Orally Active Antagonist of the Gonadotropin Releasing Hormone Receptor (GnRH-R)
Jeffrey C. Pelletier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis
Esther Vicente et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide
Raquel Villar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Synthesis and anti-inflammatory/antioxidant activities of some new ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives and of their 4,5-dihydro-(1H)-pyrazole analogues
Asuncion Burguete et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Structure-activity relationship (SAR) studies of quinoxalines as novel HCVNS5B RNA-dependent RNA polymerase inhibitors
Frank Rong et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Diverse mechanisms of antiepileptic drugs in the development pipeline
Michael A. Rogawski
EPILEPSY RESEARCH (2006)
Synthesis, characterization and antiamoebic activity of 1-(thiazolo[4,5-b]quinoxaline-2-yl)-3-phenyl-2-pyrazoline derivatives
M Abid et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines
X Hui et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Synthesis, characterization, electropolymerization, and theoretical study of 2,3-di-(2-thienyl)quinoxaline
FR Díaz et al.
POLYMER BULLETIN (2006)
New drug candidates and therapeutic targets for tuberculosis therapy
Y Zhang et al.
DRUG DISCOVERY TODAY (2006)
Synthesis of selective SRPK-1 inhibitors:: Novel tricyclic quinoxaline derivatives
Z Székelyhidi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents
A Jaso et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
New targets and screening approaches in antimicrobial drug discovery
ED Brown et al.
CHEMICAL REVIEWS (2005)
Synthesis and preliminary in vitro evaluation of antimycobacterial activity of new pyrrolo[1,2-a]quinoxaline-carboxylic acid hydrazide derivatives
J Guillon et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2004)
Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents
A Jaso et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
The antioxidant activity of caroverine
N Udilova et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives
LE Seitz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
2,3-bifunctionalized quinoxalines: Synthesis, DNA interactions and evaluation of anticancer, anti-tuberculosis and antifungal activity
MJ Waring et al.
MOLECULES (2002)
Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity
A Carta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2002)
Syntheses and structure-activity relationships of 5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxaline derivatives with retinoic acid receptor α agonistic activity
K Kikuchi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Glutamate excitotoxicity in a model of multiple sclerosis
D Pitt et al.
NATURE MEDICINE (2000)
分享论文
